English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Thesis

Therapeutische Anwendung des Progesteronantagonisten "Onapriston" im transgenen Rattenmodell der Charcot-Marie-Tooth-Erkrankung Typ 1A (CMT1A)

MPS-Authors
/persons/resource/persons182297

Meyer zu Hörste,  Gerd
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Diss Meyer zu Hörste.pdf
(Any fulltext), 3MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Meyer zu Hörste, G. (2006). Therapeutische Anwendung des Progesteronantagonisten "Onapriston" im transgenen Rattenmodell der Charcot-Marie-Tooth-Erkrankung Typ 1A (CMT1A). PhD Thesis, Georg-August-Universität, Göttingen.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002A-1FBB-2
Abstract
There is no abstract available